Adult mortality at 5 DAT was similar to the 3 DAT trials, except that methomyl, phosmet, and spinosad retained the highest levels of activity. By 7 DAT, only the phosmet treatment was significantly different from the untreated control, and this was the only treatment providing high levels of mortality at 10 DAT.